These medications have both been manufactured specifically to support women who have been struggling with sexual function and satisfaction. They are both available as generic medications, which means the cost of buying them has been reduced significantly for consumers. Lovegra 100mg contains 100 mg of sildenafil, also the active compound in Viagra. Addyi 100mg contains a unique compound called flibanserin, which is only found in this medication.
Women with the four conditions below are the main users:
Lovegra 100mg and Addyi 100mg differ in the specific conditions they are designed to treat. Below is a guide to the specific indications for each of the medications being discussed.
Each of these medications has been through an extensive clinical trials procedure before being approved for use, which has indicated their excellent safety profiles. That said, side effects are still something users should be aware of, some people should discuss use with a medical professional, especially if they are using nitrate medication or have underlying conditions.
Lovegra 100 mg Side effects:
Addyi 100 mg side effects:
When it comes to Lovegra 100mg vs Addyi 100mg, the former is usually much more affordable due to the active compound being found in numerous medications, which brings down the cost of production. Here is a rough guide below, go to our homepage for a full list of options with prices:
In summary, Lovegra 100mg and Addyi 100mg are both medications that aim to address sexual dysfunction in women. Lovegra 100mg enhances blood flow and arousal, while Addyi 100mg specifically increases desire. Each option has its unique advantages and considerations. More information on each product can be accessed from the individual product page.
Choose kamagradeutschland.com for a trusted and effective solution to female sexual dysfunction.
Dr Hartman Welf is a renowned medical expert in the fields of urology and sexual health. He completed his undergraduate studies in Medicine at the University of Hamburg and later specialized in Urology and Sexual Health at the Ludwig Maximilian University of Munich.
Last Reviewed: March 2023
Next Review Due: March 2024
Your email address will not be published.
Required fields are marked *